Distribution of scopolamine into brain following intranasal administration
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Poster
- By: LIU, Wei (The 88th hospital, Taian, Shandong Province, China)
- Co-author(s): HU, Guan-shi (The General Hospital, JI'NAN,SHANDONG PROVINCE, China)
Scopolamine is an anticholinergic agent approved for use in the prevention of nausea and vomiting associated with motion sickness. Scopolamine is well absorbed after oral, parenteral administration. However, the amount of scopolamine in the brain is limited due to blood-brain-barrier, which causes the inadequate effect of agents. Therefore,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.